Health knowledge made personal
Please enter a search word or phrase.
The search word cannot have more than 100 characteres.
Mediastinal Fibrosis - Articles
WHY DO MY SYMPTOMS IMPROVE ON ANTIBIOTICS BUT DETERIORATE WHEN I STOP?
by
Joanne60
Posted
Sun 18 Nov 2012 5:05pm
Why does my arthritis get better when I take antibiotics but deteriorate when I stop?
Why does my muscle weakness get better on antibiotics but deteriorate when I stop?
Why does my fatigue and Fibromyalgia get better when I take antibiotics but deteriorate when I stop?
Why do my chronic symptoms improve on antibiotics for urinary tract infecti ...
Read on »
Nephrogenic systemic fibrosis: an unusual scleroderma-like fibrosing disorder
by
Jan
Posted
Wed 09 Mar 2011 2:16am
Nephrogenic systemic fibrosis (NSF) is a fibrosing disorder, recently described in patients with advanced chronic kidney disease, usually after exposure to gadolinium (Gd)-based contrast agents, characterized by progressive fibrotic involvement mainly of the skin.
At clinical examination, the cutaneous findings of NSF may partly resemble th ...
Read on »
Pulmonary Fibrosis in Systemic Sclerosis: Association With Myocardial Fibrosis
by
Jan
Posted
Sun 05 Dec 2010 9:03pm
Purpose:
To evaluate the relationship between pulmonary and myocardial fibrosis in patients with systemic sclerosis (SS).
Materials and Methods:
Eighteen patients with SS prospectively underwent cardiac magnetic resonance imaging (CMR) and high-resolution computed tomography (HRCT) of the chest. Cardiac biomarkers (N-terminal pr ...
Read on »
New pharmacological strategies for the treatment of pulmonary fibrosis
by
Jan
Posted
Sun 27 Mar 2011 9:25am
The treatment of pulmonary fibrosis continues to pose major difficulties. Idiopathic pulmonary fibrosis (IPF), the most prevalent chronic fibrosing lung disease, is a devastating condition that carries a prognosis worse than that of many cancers. Abnormalities in multiple pathways involved in wound healing and inflammation lead to the development ...
Read on »
Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled
by
Jan
Posted
Sat 01 May 2010 12:00am
A. U. Wells
CORRESPONDENCE: A. U. Wells, Royal Brompton Hospital, Fulham Rd, London SW3 6HP, UKFax: . E-mail: a.wells@rbh.nthames.nhs.uk
The new American Thoracic Society/European Respiratory Society classification of the idiopathic interstitial pneumonias 1 has redefined entities previously grouped as "idiopathic pulmonary fibrosis" ( ...
Read on »
Genetics Home Reference: congenital hepatic fibrosis
by
nih.gov
Posted
Wed 25 Jan 2012 2:54pm
On this page:
Description
Genetic changes
Inheritance
Treatment
Additional information
Other names
Glossary definitions
Reviewed January 2012
What is congenital hepatic fibrosis?
Congenital hepatic fibrosis is a disease of the liver that is pres ...
Read on »
Can dialysis prevent nephrogenic systemic fibrosis?
by
Matt S.
Posted
Sun 25 Jan 2009 12:00am
There has been a lot of literature over the past few years regarding the identification of gadolinium-based contrast dye as the driving force behind the dermatologic fibrosing condition nephrogenic systemic fibrosis (NSF). While there remain doubters that gadolinium has definitively been shown to be the cause of this disease--an admittedly ...
Read on »
Finger Clubbing in Cystic Fibrosis
by
Lauren B.
Posted
Mon 25 Aug 2008 7:27pm
One of the prevailing physical signs of cystic fibrosis is noticeable digital clubbing. Digital clubbing is a condition in which the tips of fingers or toes have an unusually large amount of excess tissue. This results in the nail bed taking on a curved appearance. This rounding of the fingertips is easily recognized by viewing the fingers f ...
Read on »
Gall Bladder Issues in Cystic Fibrosis
by
Lauren B.
Posted
Mon 25 Aug 2008 7:27pm
The gall bladder is a small, pear-shaped organ that connects to the liver by a series of ducts. As part of the digestive system, the gallbladder’s role is to store bile (a bitter liquid produced by the liver) that will be used to digest food, particularly fat, on its way to the small intestine.
Nearly every cystic fibrosis (CF) p ...
Read on »
Posted
Sat 22 Oct 2011 10:04pm
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns. The trial found that people with IPF receiving ...
Read on »
